About Us

Whether you are an investor seeking to support groundbreaking medical solutions or a channel or technology partner ready to collaborate on cutting-edge projects, we warmly welcome you to join us in driving the future of biomedical innovation.

Management

Mr. Huang is the Chairman of Jim Brother’s Corporation and Fixwell Technology Corp. In addition to being an president of a footwear factory, Mr. Huang also successfully founded a semiconductor company, Fixwell Technology. Currently, Mr. Huang devotes all his efforts to running BBB to be a successful new drug company.

Dr. Lin is a biomedical scientist with over 20 years of commercial process in life science industries, including medical devices, pharmaceutical, biomaterials manipulate technology and biochips.
Prior to joining Blue Blood Biotech Corp., Dr. Lin was the Deputy Project Director of Industrial Technology.

Innovation Team

Dr. Ding holds a Ph.D. in Microbiology from National Chung Hsing University, with a focus on Bacteriology, Bioinformatics, and Molecular Biotechnology. With over 10 years of research experience in microbial genomics, microbial ecology, and related fields, Dr. Ding has an extensive background in advanced microbiological studies.
Dr. Ding oversees product development and market analysis with more than three years of experience in this role. Leveraging expertise in microbiology, Dr. Ding also leads the integration of AI-driven technologies to optimize recombinant protein production.

Advisory Board

Dr. Wu is a professor of Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University. Wu is specialized in enzymology, protein chemistry, proteases in clinical biochemistry, cardiovascular disease and etc.

Dr. Shi is a professor of Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University.

獎項